Mission

ICER's mission is to lead innovation in comparative effectiveness research through methods that integrate considerations of clinical benefit and economic value.  Through a unique collaboration with patients, clinicians, manufacturers, insurers and other healthcare stakeholders, ICER develops tools to support patient decisions and medical policy that share the goal of achieving maximum value for every healthcare dollar.

Staff Only

Remember Me
Advisory Board Conflict of Interest Policy

In order to avoid any potential conflict of interest with the mission of ICER, ICER has adopted the following statement to guide its Advisory Board on issues of conflict of interest, disclosure, and recusal.  

 

I.  ICER has been purposely structured as a fully transparent organization that is able to engage with all key stakeholders in its appraisals while retaining complete independence in the formulation of its conclusions and the drafting of its reviews.   

II.  The ICER Advisory Board is a completely voluntary group that includes representatives of organizations financially supporting ICER activities along with independent health policy experts and representatives of other organizations with an interest in the application of evidence to medical policy.

III.  The Advisory Board does not govern ICER in any way.  The function of the Advisory Board is solely to provide perspective and advice to ICER staff on how ICER can best fulfill its mission.  

IV.  Because there are organizations represented on the Board who compete in the health care marketplace, ICER staff and all Advisory Board members will refrain from any discussion that could provide the basis for an inference that members considered any action that might restrain trade in any way.

V.  At no time will the Advisory Board discuss the scientific or methodological merits of any specific technology appraisal.  However, if for whatever reason a topic arises during an Advisory Board meeting that could have competitive repercussions in a therapeutic area in which manufacturing industry representatives compete, they must disclose to the Board that they have a potential conflict and leave the room during the remainder of that discussion.  Meeting minutes will document the recusal.  Given that the Advisory Board is removed from discussions that involve consideration of specific interventions it will be extremely unlikely that this form of recusal would be required at any time.